Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias. / Gardner, R T; Wang, L; Lang, B T; Cregg, J M; Dunbar, C L; Woodward, W R; Silver, J; Ripplinger, C M; Habecker, B A.
In: Nature Communications, Vol. 6, 6235, 02.02.2015.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Targeting protein tyrosine phosphatase σ after myocardial infarction restores cardiac sympathetic innervation and prevents arrhythmias
AU - Gardner, R T
AU - Wang, L
AU - Lang, B T
AU - Cregg, J M
AU - Dunbar, C L
AU - Woodward, W R
AU - Silver, J
AU - Ripplinger, C M
AU - Habecker, B A
PY - 2015/2/2
Y1 - 2015/2/2
N2 - Millions of people suffer a myocardial infarction (MI) every year, and those who survive have increased risk of arrhythmias and sudden cardiac death. Recent clinical studies have identified sympathetic denervation as a predictor of increased arrhythmia susceptibility. Chondroitin sulfate proteoglycans present in the cardiac scar after MI prevent sympathetic reinnervation by binding the neuronal protein tyrosine phosphatase receptor σ (PTPσ). Here we show that the absence of PTPσ, or pharmacologic modulation of PTPσ by the novel intracellular sigma peptide (ISP) beginning 3 days after injury, restores sympathetic innervation to the scar and markedly reduces arrhythmia susceptibility. Using optical mapping we observe increased dispersion of action potential duration, supersensitivity to β-adrenergic receptor stimulation and Ca(2+) mishandling following MI. Sympathetic reinnervation prevents these changes and renders hearts remarkably resistant to induced arrhythmias.
AB - Millions of people suffer a myocardial infarction (MI) every year, and those who survive have increased risk of arrhythmias and sudden cardiac death. Recent clinical studies have identified sympathetic denervation as a predictor of increased arrhythmia susceptibility. Chondroitin sulfate proteoglycans present in the cardiac scar after MI prevent sympathetic reinnervation by binding the neuronal protein tyrosine phosphatase receptor σ (PTPσ). Here we show that the absence of PTPσ, or pharmacologic modulation of PTPσ by the novel intracellular sigma peptide (ISP) beginning 3 days after injury, restores sympathetic innervation to the scar and markedly reduces arrhythmia susceptibility. Using optical mapping we observe increased dispersion of action potential duration, supersensitivity to β-adrenergic receptor stimulation and Ca(2+) mishandling following MI. Sympathetic reinnervation prevents these changes and renders hearts remarkably resistant to induced arrhythmias.
KW - Animals
KW - Arrhythmias, Cardiac/prevention & control
KW - Calcium/metabolism
KW - Electrocardiography
KW - Female
KW - Male
KW - Mice
KW - Mice, Inbred BALB C
KW - Mice, Transgenic
KW - Myocardial Infarction/drug therapy
KW - Peptides/therapeutic use
KW - Receptor-Like Protein Tyrosine Phosphatases, Class 2/antagonists & inhibitors
KW - Receptors, Adrenergic, beta/metabolism
KW - Sympathetic Nervous System/metabolism
U2 - 10.1038/ncomms7235
DO - 10.1038/ncomms7235
M3 - Journal article
C2 - 25639594
VL - 6
JO - Nature Communications
JF - Nature Communications
SN - 2041-1723
M1 - 6235
ER -
ID: 248114734